| Literature DB >> 28466248 |
David E Simmons1, Pooja Maney1, Austin G Teitelbaum1, Susan Billiot1, Lomesh J Popat2, A Archontia Palaiologou3.
Abstract
BACKGROUND: The purpose of this study was to compare a parallel wall design implant to a tapered apex design implant when placed in the posterior maxilla using two different surgical protocols.Entities:
Keywords: Dental implants; Implant stability; Implant survival; OsseoSpeed TX™; OsseoSpeed™; Osstell™; Resonance frequency analysis
Year: 2017 PMID: 28466248 PMCID: PMC5411487 DOI: 10.1186/s40729-017-0078-2
Source DB: PubMed Journal: Int J Implant Dent ISSN: 2198-4034
Fig. 1Implant design. The OSPTX and OSP implants are manufactured from high-grade commercially pure titanium with surface roughness produced via a fluoride treatment process. The OSP implant is a screw-shaped self-tapping implant. The diameter used in this study was 4.0 mm. The implant length used in this study was 8 mm. The OSPTX implant has the same features as the OSP except the apex of the implant is tapered
Patient selection criteria
| Inclusion | Male or female |
| At least 18 years old | |
| Healthy enough to undergo routine implant surgery and subsequent dental treatment | |
| Partially edentulous requiring single dental implants in the maxilla | |
| Adequate volume of native or grafted bone to accommodate dental implants at least 8 mm long | |
| No active infections | |
| Physically, emotionally, and financially able to undergo planned implant procedures | |
| Adequate compliance to meet study requirements and necessary appointments | |
| Exclusion | Medical need for antibiotic premedication for infective endocarditis, artificial joints, or any other medication |
| Uncontrolled hypertension | |
| Uncontrolled diabetes | |
| Serological human immunodeficiency virus (HIV) positive | |
| History of significant heart, stomach, liver, kidney, blood, immune system, or other organ impairment or systemic disease that would prevent undergoing the proposed treatment | |
| Smoke cigarettes or other tobacco products | |
| Use of investigational drugs during the previous month | |
| Unresolved dental conditions likely to require exiting the study for treatment, such as deep cavities, abscesses, or moderate to severe periodontal disease | |
| History of radiation therapy to the head and neck | |
| Unwilling or inability to sign the informed consent form | |
| Failure to demonstrate willingness to return for a required number of visits | |
| Need immediate dental implant placement following tooth extraction |
Patient selection, inclusion, and exclusion criteria are presented
Fig. 2ISQ values at placement, 6 weeks, 6 months, and 1 year. Mean and standard deviation of ISQ values taken at placement, 6 weeks, 6 months, and 1 year is presented. No statistical significant difference was determined between ISQ values at all time points. (p < 0.05)
Fig. 3Mean bone loss at 6 months and 1 year. Mean bone loss distribution charts at 6 months and 1 year present no statistically significant difference. p value at 6 months was 0.2981 and at 1 year 0.6613
Outcome success criteria
| Implant success | Clinically immobile when tested manually and/or with RFA (minimum ISQ = 65) |
| Absence of peri-implant radiolucency present on an undistorted radiograph | |
| Absence of unresolved pain, discomfort, infection or neuropathy, or peri-implant soft tissue complications attributable to the implant | |
| Implant placement that does not preclude delivery of a prosthetic crown with an appearance that is satisfactory to the patient and the dentist | |
| Crestal bone loss that is <1.5 mm after the first year of loading followed by not more than 0.2 mm of annual crestal bone loss thereafter | |
| Prosthesis success | Absence of unresolved peri-implant soft-tissue complications, such as bleeding, swelling, suppuration or recession, attributable to the prosthetic restoration |
| Absence of unresolved prosthetic complications, such as screw loosening or porcelain fracture | |
| Absence of esthetic complications, such as implant or abutment visibility, or compromised porcelain translucency or mismatched prosthetic tooth color | |
| Early loading success: a functional provisional crown placed ≥3 weeks and <3–6 months after implant placement, followed by delivery of a definitive crown after 12 months of function |
Outcome success criteria are presented